Emily R Adams Selected Research

Emily R Adams Research Topics

Disease

11	Infections 02/2024 - 04/2010
10	COVID-19 01/2023 - 08/2020
6	Leishmaniasis 01/2022 - 11/2013
5	Malaria 02/2024 - 05/2014
5	Visceral Leishmaniasis (Kala Azar) 01/2022 - 04/2010
4	Glucosephosphate Dehydrogenase Deficiency 02/2024 - 04/2021
4	Schistosomiasis (Bilharziasis) 01/2021 - 01/2018
3	Asymptomatic Infections 01/2022 - 12/2015
3	Helminthiasis (Helminthiases) 01/2020 - 01/2018
2	Dengue (Dengue Fever) 01/2023 - 01/2020
2	Coinfection 01/2022 - 05/2014
2	Hemolysis 01/2022 - 04/2021
2	Cutaneous Leishmaniasis 12/2014 - 04/2010
1	Severe Acute Respiratory Syndrome 01/2023
1	Sepsis (Septicemia) 01/2022
1	Trachoma 01/2021
1	Convalescence 01/2021
1	Tuberculosis (Tuberculoses) 12/2020
1	Schistosomiasis mansoni 04/2020
1	Rupture 04/2017
1	Neglected Diseases 01/2015

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2023 - 04/2020
4	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 02/2024 - 04/2021
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
4	AntibodiesIBA 01/2022 - 08/2020
3	EnzymesIBA 02/2024 - 01/2022
3	Immunoglobulin M (IgM)IBA 01/2023 - 01/2020
3	Praziquantel (Biltricide)FDA Link 04/2020 - 01/2018
2	Complement System Proteins (Complement)IBA 02/2024 - 11/2018
2	VaccinesIBA 01/2023 - 01/2022
2	tafenoquineIBA 01/2022 - 04/2021
2	Primaquine FDA Link 01/2022 - 04/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 12/2014
2	Albendazole (Albenza)FDA Link 01/2020 - 01/2018
2	leishmaninIBA 12/2018 - 12/2015
2	InterferonsIBA 04/2017 - 05/2014
1	Tetrazolium SaltsIBA 02/2024
1	beta-Lactamases (beta-Lactamase)IBA 01/2023
1	carbapenemaseIBA 01/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Therapeutic UsesIBA 01/2022
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 04/2021
1	Antimalarials (Antimalarial Agents)IBA 04/2021
1	Third Generation CephalosporinsIBA 01/2019
1	Chloramphenicol (Chloromycetin)FDA Link 01/2019
1	piperaquineIBA 01/2019
1	artenimol (dihydroartemisinin)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	hemozoinIBA 04/2017
1	LipopolysaccharidesIBA 04/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017
1	Kinetoplast DNA (kDNA)IBA 12/2015
1	Interleukin-10 (Interleukin 10)IBA 05/2014
1	CytokinesIBA 05/2014
1	Interleukin-13IBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	Interleukin-17 (Interleukin 17)IBA 05/2014
1	Interleukin-4 (Interleukin 4)IBA 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014
1	InterleukinsIBA 05/2014
1	Cysteine Proteases (Cysteine Protease)IBA 11/2013
1	Nucleic AcidsIBA 04/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2014
3	Mass Drug Administration 01/2021 - 01/2015